Pediatrix Medical Group, Inc. (NYSE:MD) Q4 2023 Results Conference Call February 20, 2024 9:00 AM ET Company Participants Charles Lynch - SVP, Finance & Strategy Jim Swift - CEO Marc Richards - CFO Conference Call Participants Jack Senft - William Blair Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, thank you for standing by. Welcome to the 2023 Fourth Quarter Earnings Conference Call. [Operator Instructions]. As a reminder, this ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from to Commission file number 001-12111 Pediatrix Medical Group, Inc. (Exact name of registrant as specified in its charter) FLORIDA 26-3667538 (State or other jurisdiction (I.R.S. Employer of ...

Pediatrix Medical Group, Inc. (NYSE:MD) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy Dr. Jim Swift - Chief Executive Officer Marc Richards - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Medical Group, Inc. Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a liste ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 1301 Concord Terrace Sunrise, Florida 33323 (Address of principal executive offices) (Zip Code) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-12111 Pediatrix Medical ...

Start Time: 09:00 January 1, 0000 9:26 AM ET Pediatrix Medical Group, Inc. (NYSE:MD) Q2 2023 Earnings Conference Call August 03, 2023, 09:00 AM ET Company Participants Jim Swift - CEO Marc Richards - EVP and CFO Charles Lynch - SVP, Finance and Strategy Conference Call Participants Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Second Quarter Earnings Conference Call. At this time, your telephone lines are in a l ...

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-12111 Pediatrix Medical Group, Inc. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or oth ...

Pediatrix Medical Group, Inc. (NYSE:MD) Q1 2023 Earnings Conference Call May 2, 2023 9:00 AM ET Company Participants Charles Lynch - SVP, Finance and Strategy Jim Swift - CEO Marc Richards - CFO Conference Call Participants Kevin Fischbeck - Bank of America Taji Phillips - Jefferies Jack Senft - William Blair A.J. Rice - Credit Suisse Kieran Ryan - Deutsche Bank Whit Mayo - SVB Securities Operator Ladies and gentlemen, thank you for standing by. Welcome to the First Quarter 2023 Earnings Conference Call. [O ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-12111 Pediatrix Medical Group, Inc. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or othe ...

Pediatrix Medical Group, Inc. (NYSE:MD) Q4 2022 Earnings Conference Call February 17, 2023 9:00 AM ET Company Participants Charles Lynch ??? Senior Vice President, Finance and Strategy Mark Ordan ??? Executive Chair Jim Swift ??? Chief Executive Officer Marc Richards ??? Chief Financial Officer Conference Call Participants Jack Senft ??? William Blair AJ Rice ??? Credit Suisse Pito Chickering ??? Deutsche Bank Whit Mayo ??? SVB Securities Kevin Fischbeck ??? Bank of America Rishi Parekh ??? JPMorgan Tao Qi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from to Commission file number 001-12111 Pediatrix Medical Group, Inc. (Exact name of registrant as specified in its charter) FLORIDA 26-3667538 (State or other jurisdiction (I.R.S. Employer of ...